{
  "id" : "seer_primary_tumor_43302",
  "algorithm" : "eod_public",
  "version" : "3.3",
  "name" : "EOD Primary Tumor",
  "title" : "EOD Primary Tumor",
  "notes" : "**Note 1:** **Islets of Langerhans** \n* Islets of Langerhans are distributed throughout the pancreas; an islet tumor is coded according to the subsite of the pancreas in which the tumor arises if the information is available.\n\n**Note 2:** **Abutment, encasement** \n* The terms \"abutment,\" \"abut(s),\" \"encases,\" or \"encasement\" of the major blood vessels can be interpreted as involvement of these structures.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(5) Bergsland, E.K., Woltering, E.A., Klimstra, D.S., et al. **Neuroendocrine Tumors of the Pancreas**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(6) **Neuroendocrine Tumors of the Pancreas**, from the AJCC Cancer Staging System Version 9 (2023). Used with permission of the American College of Surgeons, Chicago, Illinois.",
  "last_modified" : "2025-09-18T20:51:49.913Z",
  "definition" : [ {
    "key" : "eod_primary_tumor",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "ss2018_t",
    "name" : "SS2018 T",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "000", "In situ: Noninvasive, intraepithelial", "VALUE:IS" ], [ "100", "Any size tumor\n\nConfined to pancreas\n\nLocalized, NOS", "VALUE:L" ], [ "200", "Peripancreatic (adipose) tissue\nPeripancreatic fat", "VALUE:RE" ], [ "300", "Ampulla of Vater\nBile duct, NOS\nCommon bile duct\nDuodenum", "VALUE:RE" ], [ "500", "All sites\n- Portal vein\n- Stomach\n- Superior mesenteric vein\n\nHead of pancreas\n- Adjacent stomach\n- Gastroduodenal artery/vein\n- Transverse colon, including hepatic flexure\n\nBody and/or tail of pancreas\n- Spleen\n- Splenic artery/vein\n- Splenic flexure\n\nFixation to adjacent structures, NOS", "VALUE:RE" ], [ "600", "All Sites\n- Aortic artery\n- Celiac [axis] artery\n- Common hepatic artery\n- Superior mesenteric artery\n\nFurther contiguous extension to other major arteries", "VALUE:RE" ], [ "700", "All sites\n- Adrenal gland/suprarenal gland\n- Gallbladder\n- Kidney\n- Liver, including porta hepatis\n- Mesenteric fat\n- Mesentery\n- Mesocolon\n- Peritoneum\n- Retroperitoneum\n- Small intestine (excluding duodenum, see code 500)\n- Ureter\n\nHead of pancreas\n- Colon (other than transverse colon including hepatic flexure, see code 500)\n- Omentum\n- Spleen\n\nBody and/or tail of pancreas\n - Colon (other than splenic flexure)\n - Diaphragm\n\nFurther contiguous extension to other organs", "VALUE:D" ], [ "800", "No evidence of primary tumor", "VALUE:U" ], [ "999", "Unknown; extension not stated\nPrimary tumor cannot be assessed\nNot documented in medical record\n\nDeath Certificate Only", "VALUE:U" ] ]
}